Pre-Clinical Development of CT-1119, a Mesothelin-Targeting Chimeric Antigen Receptor Macrophage

被引：0
|
作者：
Anderson, Nicholas R. [1 ]
Shah, Brinda [1 ]
Worth, Alison [1 ]
Gabbasov, Rashid [1 ]
Menchel, Brett [1 ]
Ciccaglione, Kerri [1 ]
Blumenthal, Daniel [1 ]
Pierini, Stefano [1 ]
DeLong, Sabrina Ceeraz [1 ]
Abramson, Sascha [1 ]
Condamine, Thomas [1 ]
Klichinsky, Michael [1 ]
机构：
[1] Carisma Therapeut, Philadelphia, PA USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
751
引用
收藏
页码：373 / 373
页数：1
相关论文
共 50 条
  • [31] PRE-CLINICAL STUDY AND CLINICAL DEVELOPMENT OF AXL-TARGETING THERAPY FOR RECURRENT GLIOBLASTOMA
    Sadahiro, Hirokazu
    Kang, Kyung-Don
    Nabors, Burt
    Norian, Lyse
    Hambardzumyan, Dolores
    Dasgupta, Biplab
    Nakada, Mitsutoshi
    Nakano, Ichiro
    NEURO-ONCOLOGY, 2017, 19 : 56 - 56
  • [32] Understanding clinical development of chimeric antigen receptor T cell therapies
    De Wilde, Sofieke
    Guchelaar, Henk-Jan
    Zandvliet, Maarten Laurens
    Meij, Pauline
    CYTOTHERAPY, 2017, 19 (06) : 703 - 709
  • [33] Development of chimeric antigen receptor T cells targeting cancer-expressing podocalyxin
    Mishima, Yuta
    Okada, Shintaro
    Ishikawa, Akihiro
    Wang, Bo
    Waseda, Masazumi
    Kaneko, Mika K.
    Kato, Yukinari
    Kaneko, Shin
    REGENERATIVE THERAPY, 2025, 28 : 292 - 300
  • [34] Development of Chimeric Antigen Receptor Macrophages Targeting Amyloid-β in Alzheimer's Disease
    Davis, Mara
    Oon, Krystal
    Paniagua, Matias Porras
    Bennett, Chris
    Gill, Saar
    MOLECULAR THERAPY, 2024, 32 (04) : 22 - 23
  • [35] Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer
    Ko, Andrew H.
    Jordan, Alexander C.
    Tooker, Evan
    Lacey, Simon F.
    Chang, Renee B.
    Li, Yan
    Venook, Alan P.
    Tempero, Margaret
    Damon, Lloyd
    Fong, Lawrence
    O'Hara, Mark H.
    Levine, Bruce L.
    Melenhorst, J. Joseph
    Plesa, Gabriela
    June, Carl H.
    Beatty, Gregory L.
    MOLECULAR THERAPY, 2020, 28 (11) : 2367 - 2378
  • [36] Fc Receptor Targeting Reduces Bone Disease in a Pre-Clinical Model of Multiple Myeloma
    Williams, Mark T.
    Thuemmler, Katya
    Kitson, Susan
    Soutar, Richard
    Goodyear, Carl S.
    BLOOD, 2015, 126 (23)
  • [37] Pre-Clinical Evaluation of B7-H3-Specific Chimeric Antigen Receptor T-Cells for the Treatment of Acute Myeloid Leukemia
    Lichtman, Eben
    Du, Hongwei
    Savoldo, Barbara
    Ferrone, Soldano
    Li, Guangming
    Su, Lishan
    Dotti, Gianpietro
    BLOOD, 2018, 132
  • [38] Humanization and Pre-Clinical Validation of an Anti-HLA-A*02:01 Chimeric Antigen Receptor for use with Regulatory T cells to Enhance Transplant Tolerance
    Dawson, Nicholas A. J.
    Lamarche, Caroline
    Bergqvist, Peter
    Huang, Qing
    Mojibian, Majid
    Gillies, Jana
    Orban, Paul C.
    Hoeppli, Romy
    Levings, Megan K.
    TRANSPLANTATION, 2018, 102 : S233 - S233
  • [39] Development of Chimeric Antigen Receptor (CAR) T Cells Targeting MET in Lymphomas and Solid Tumors
    Chen, Pohan
    Raghunandan, Rianna
    Muschen, Markus
    Katz, Samuel G.
    BLOOD, 2023, 142
  • [40] Pre-clinical study targeting metabotropic glutamate receptor (GRM1) angiogenesis pathway
    Grabell, Daniel A.
    Wen, Yu
    Semlani, Neha
    Li, Jiadong
    Goydos, James
    CANCER RESEARCH, 2013, 73 (08)
12345